Skip to main content
Top
Published in: European Journal of Epidemiology 12/2019

01-12-2019 | Mastectomy | SCREENING

Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program

Authors: Pietro Trocchi, Oliver Kuss, Vanessa Kääb-Sanyal, Oliver Heidinger, Andreas Stang

Published in: European Journal of Epidemiology | Issue 12/2019

Login to get access

Abstract

In Germany, the nationwide population-based mammography screening program (MSP) was introduced in 2005 and is full-running since 2010. By 2014, incidence rates for invasive breast cancer were very similar to those of the pre-screening era. Therefore, the ongoing effect of the MSP on breast cancer surgery rates can now be investigated. We analyzed population-based breast-conserving (BCS) and mastectomy (MET) surgery rates (per 100,000) among women aged < 50, 50–69 (eligible for the MSP), and 70+ years among women with in situ and invasive breast cancer during 2005–2015. For invasive breast cancer, both BCS and MET rates slightly increased in the age group < 50 years (38.3 in 2005 vs 42.5 in 2015 and 15.7 vs 18.2, respectively). In contrast, MET rates considerably decreased among women aged 50–69 and 70+ years (92 vs 65.4 and 155.4 vs 122.1, respectively), while BCS rates increased in both age groups (210.6 vs 254.4 and 147.2 vs 187, respectively). For in situ breast cancer, MET rates slightly increased in all age groups. BCS rates slightly increased in women aged < 50, but nearly doubled for women aged 50–69 (26.9 vs 49.1) and markedly increased in the 70+ age group (11.5 vs 16.1). During and after the implementation of MSP, there was a strong shift towards BCS within the screening-eligible age group and for women aged 70+ . Women with invasive breast cancer in these age groups may profit from screening with a decline of MET rates in favor of BCS rates at the expense of higher surgery rates for in situ breast cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Krebs in Deutschland für 2013/2014. 11. ed. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.; 2017. Krebs in Deutschland für 2013/2014. 11. ed. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.; 2017.
3.
go back to reference Pathology EWGoBS. Quality assurance guidelines for pathology. In: Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Brussels: European Union; 2006. p. 219–312. Pathology EWGoBS. Quality assurance guidelines for pathology. In: Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Brussels: European Union; 2006. p. 219–312.
4.
go back to reference Evaluation Jahresbericht. Deutsches mammographie-screening-programm. Berlin: Kooperationsgemeinschaft Mammographie; 2015. p. 2017. Evaluation Jahresbericht. Deutsches mammographie-screening-programm. Berlin: Kooperationsgemeinschaft Mammographie; 2015. p. 2017.
5.
go back to reference Krebsgeschehen in Nordrhein-Westfalen 2015. Jahresbericht 2017. Bochum Landeskrebsregister NRW gGmbH (Hrsg.); 2018. Krebsgeschehen in Nordrhein-Westfalen 2015. Jahresbericht 2017. Bochum Landeskrebsregister NRW gGmbH (Hrsg.); 2018.
11.
go back to reference Suhrke P, Maehlen J, Schlichting E, Jorgensen KJ, Gotzsche PC, Zahl PH. Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ. 2011;343:d4692.CrossRef Suhrke P, Maehlen J, Schlichting E, Jorgensen KJ, Gotzsche PC, Zahl PH. Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ. 2011;343:d4692.CrossRef
16.
go back to reference Bericht zum Krebsgeschehen in Deutschland 2016. Berlin: Robert Koch-Institut; 2016. Bericht zum Krebsgeschehen in Deutschland 2016. Berlin: Robert Koch-Institut; 2016.
19.
go back to reference Tillmanns H, Schillinger G, Dräther H. Früherkennung bei Erwachsenen in der gesetzlichen Krankenversicherung: Ergebnisse einer AOK-Sekundärdatenanalyse. Versorgungs-Report Früherkennung. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2019. p. 49–69.CrossRef Tillmanns H, Schillinger G, Dräther H. Früherkennung bei Erwachsenen in der gesetzlichen Krankenversicherung: Ergebnisse einer AOK-Sekundärdatenanalyse. Versorgungs-Report Früherkennung. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2019. p. 49–69.CrossRef
Metadata
Title
Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program
Authors
Pietro Trocchi
Oliver Kuss
Vanessa Kääb-Sanyal
Oliver Heidinger
Andreas Stang
Publication date
01-12-2019
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 12/2019
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-019-00570-x

Other articles of this Issue 12/2019

European Journal of Epidemiology 12/2019 Go to the issue